A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia	Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic disease	Not yet recruiting	Phase 3	2026-07-06		NCT07680829

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Zhejiang Doer Biologics Co., Ltd.	7

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking University First Hospital	Beijing	China	72
Peking University People's Hospital	Beijing	China	68

Clinical trials